Karol Bagh | IAS GS Foundation Course | 17 October | 8 AM. Call Us
This just in:

State PCS


News Analysis


Important Facts For Prelims

National Biomedical Resource Indigenization Consortium

  • 14 May 2020
  • 2 min read

Why in News

Recently, the Department of Biotechnology (DBT) has launched a National Biomedical Resource Indigenization Consortium (NBRIC) to drive indigenous innovation focused on developing reagents (used in chemical reactions), diagnostics, vaccines and therapeutics for Covid-19.

Key Points

  • It is a ‘Make in India’ initiative for biomedical research and innovative products, towards promoting import substitution and exports.
  • It aims to establish a nation-wide collaborative platform for convergence of research, product resources and services towards developing reagents, diagnostics, vaccines, and therapeutics across India.
  • It identifies providers/manufacturing enterprises of crucial bio-medical resources and connects them with policy makers as well as with other stakeholders from public and private sectors.

Centre for Cellular and Molecular Platforms

  • Centre for Cellular and Molecular Platforms (C-CAMP) is one of the centers for technology-based innovation and entrepreneurship in the field of life sciences under the Department of Biotechnology (DBT).
  • It intends to develop state-of-the-art technologies and to provide training on these technologies to academia and industry.

Source:PIB

close
SMS Alerts
Share Page
images-2
images-2